Carregant...
The use of PROMIS patient-reported outcomes (PROs) to inform light chain (AL) amyloid disease severity at diagnosis
We sought to evaluate how PROMIS patient-reported outcome (PRO) measures correlated with disease characteristics in systemic light chain (AL) amyloidosis patients at diagnosis. Newly diagnosed AL patients were recruited at 2 centers (N=61). Patients completed the PROMIS Global Health v1.2, PROMIS-29...
Guardat en:
| Publicat a: | Amyloid |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7275879/ https://ncbi.nlm.nih.gov/pubmed/31971467 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13506129.2020.1713743 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|